Here are relevant reports on : analytical-instruments-market
-
Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics (IHC, ISH), Genomics (LCM), Service Type (Sample Prep, Sequencing), Application (Translation Research (Cancer)) - Global Forecast to 2029
The global spatial genomics & transcriptomics market, valued at US$532.7 million in 2023, stood at US$554.5 million in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2029, culminating in a forecasted valuation of US$995.7 million by the end of the period. Market growth is attributed to factors such as increasing adoption of spatial genomics and transcriptomics in drug discovery and development, increasing pharmaceutical R&D investments and public-private funding, introduction of technologically advanced instruments for spatial genomics analysis, and the introduction of novel products are driving the growth of the spatial genomics & transcriptomics market.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Protein Expression Market by Product (Reagents, Vectors, Competent Cells, Instruments, Software), Services, System Type (Mammalian (CHO, HEK293), Insect, Yeast), Workflow, Application (Therapeutic, Research, Industrial) - Global Forecast to 2029
The global protein expression market, valued at US$3.34 billion in 2023, stood at US$3.41 billion in 2024 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2029, culminating in a forecasted valuation of US$4.82 billion by the end of the period. This growth is driven by the increasing demand for biologics, rising R&D investments in the pharmaceutical and biopharmaceutical sectors, and the growing use of artificial intelligence and machine learning to improve protein structure and function predictions.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
APAC Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics (IHC, ISH), Spatial Genomics (FISH, Sequencing)), Product (Instruments, Consumables, Software), Application (Drug Discovery), End User (Biotech, CROs) - Forecast to 2027
The global APAC spatial genomics & transcriptomics market, stood at US$64 million in 2022 and is projected to advance at a resilient CAGR of 18.9% from 2023 to 2027, culminating in a forecasted valuation of US$152 million by the end of the period.
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Compound Management Market by Product & Outsourcing Services (Instruments (Automated Storage, Decapper), Software), Sample (Chemical Compounds, Biological Samples), End User (Biopharma Companies, Biobank, Pharma Companies, CRO) - Global Forecasts to 2023
The global compound management market is projected to reach USD 424.5 million in 2023, at CAGR of 14.5%. Increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management are the factors supporting the growth of this market. On the other hand, the large capital investments needed to establish compound management facilities is the major factor limiting market growth. The compound management market is highly competitive due to the presence of a large number of players. Few companies that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (UK), Labcyte (US), Biosero (US), and Tecan (Switzerland).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030
The global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Bottled Water Testing Equipment Market by Technology (Traditional, and Rapid), Component (Instruments, Consumables & Reagents, and Reference Material), Test Type (Microbiological, Chemical, Physical, Radiological), and Region - Global Forecast to 2021
The bottled water testing equipment market, in terms of value, is projected to reach USD 6.46 Billion by 2021, at a CAGR of 5.3% from 2016. Rapid increase in consumption of bottled water, rise in disposable income, awareness about the effects of health due to contaminated water, increase in regulations regarding bottled water quality, and technological developments in the water testing industry are some of the factors driving this market.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Acoustic Emission Testing Market by Equipment (Sensors, Amplifiers, Detection Instruments), Service (Inspection, Calibration), Application (Storage Tank, Pipeline, Aging Aircraft, Structural Monitoring, Turbine), and Geography - Global Forecast to 2035
The acoustic emission testing market is expected to be valued at USD 349.9 million by 2023, from USD 226.6 million in 2017, at a CAGR of 7.32% between 2018 and 2023. The base year considered for the study is 2017, and the forecast period is between 2018 and 2023. The report profiles the most promising players in the market. The competitive landscape presents an interesting picture, where a large number of big and small players have become a force to reckon with. The key players in this market are TUV Rheinland (Germany), MISTRAS (US), TUV Nord (Germany), Parker Hannifin (US), TUV Austria (Austria), General Electric (GE, US), Acoustic Emission Consulting (AEC, US), Vallen Systeme (Germany), KRN Services (US), and Score Atlanta (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029
The global urinalysis market, valued at US$4.0 billion in 2023, stood at US$4.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.6% from 2024 to 2029, culminating in a forecasted valuation of US$6.8 billion by the end of the period. Growth in this market is mainly driven by factors such as the increasing burden of urinary tract infections (UTIs), diabetes, and kidney & liver diseases and the increasing adoption of PoC tests.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028
The global cell analysis market, valued at US$18.6 billion in 2022, stood at US$20.2 billion in 2023 and is projected to advance at a resilient CAGR of 10.9% from 2023 to 2028, culminating in a forecasted valuation of US$33.9 billion by the end of the period. Increase in the preference for cell-bsaed assays along with strong funding for cell-based research is expected to drive the market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
